Merck KGa A officials say that, ultimately, the SMARTfacturing transformation benefits its customers, patients, and the ...

The explosion of GLP-1 weight loss drugs is reminiscent of the early days of PD-1 inhibitors, but key market differences ...

Immunovant will use results from its Phase III myasthenia gravis study to support pipeline candidate IMVT-1402 over the trial ...

Merck Foundation Song Awards “Diabetes and Hy­pertension” to promote healthy lifestyle and raise awareness about prevention of Diabetes and Hyperten­sion and healthy lifestyle promotion in Africa.

There’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a potential inflammatory diseases drug in-licensed from Germany’s Merck KGaA.

Hard on the heels of the disclosure that Merck KGaA is talking to SpringWorks about a possible takeover, a new FDA approval could have sweetened the deal. Stamford, Connecticut-based SpringWorks ...

We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors should consider ...

Merck Data at ACC.25 Highlight Innovative Advancements and Commitment to Improving Outcomes for People Living with Cardiovascular Disease ...

Merck (MRK) ended the recent trading session at $94.02, demonstrating a -0.74% swing from the preceding day's closing price. The stock's change was less than the S&P 500's daily gain of 1.08%.

PORTLAND, OR, UNITED STATES, March 20, 2025 /EINPresswire / -- The global skin cancer treatment market has exp ...

The antimicrobial properties of nisin, especially its effectiveness in inhibiting spoilage bacteria and pathogens, make it ...